Neurorehabilitation: Can the US fill gaps?
UC expert featured in MedCentral article
The University of Cincinnati's Oluwole Awosika was featured in a MedCentral article discussing the need to focus on and improve access to neurorehabilitation services following strokes and traumatic brain injuries.
A recent editorial published in The Lancet Neurology said neurorehabilitation services "are often neglected in healthcare systems across the globe.
“The ripple effects of this burden extend beyond patients and carers, leading to increased demand for health and social care services, loss of productivity, and financial strain,” the editorial continued.
Awosika, MD, recently coauthored an American Heart Association policy statement on improving access to stroke rehabilitation and recovery. He told MedCentral the editorial and a new neurorehabilitation draft guideline from the United Kingdom's National Health Service "are welcome additions to the global effort to improve post-acute care for individuals after neurologic injury.
"With the aging population and growing rates of younger individuals diagnosed with debilitating chronic neurologic conditions, it is critical that the commitment to providing patients with quality, standardized, and evidence-based care extend to the post-acute and outpatient settings,” said Awosika, associate professor in the Department of Neurology & Rehabilitation Medicine in UC’s College of Medicine and a UC Gardner Neuroscience Institute physician.
Featured photo at top of Awosika observing a person using the posturography machine. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.